Status:
COMPLETED
Ayurveda for Flu Like Illness During Covid-19 Outbreak
Lead Sponsor:
Aarogyam UK
Conditions:
Flu Like Illness
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu like illness during the Covid 19 outbreak.
Eligibility Criteria
Inclusion
- Patients with fu like symptoms within 48 hours of onset during March2020
- Mild to moderate symptoms who were advised to self isolate at home for 7-14 days
- Flu like symptoms present at least one respiratory symptom (e.g. cough, nasal obstruction, sore throat) and at least one constitutional symptom other than fever (e.g. fatigue, headache, myalgias) of less than 48-hour duration
- Willing to consent and follow up
Exclusion
- Pregnant/lactating
- Participants with chronic pulmonary diseases or critical condition or already developed severe respiratory distress
- Clinically malignancies, systemic infection, other medical or psychiatric condition which places the subject at unacceptable risk to participate in the study - Known hypersensitivity to any ayurveda herbal substances
- Severe symptoms of respiratory distress patients deemed to require intensive care immediately
Key Trial Info
Start Date :
March 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04351542
Start Date
March 6 2020
End Date
April 12 2020
Last Update
April 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarogyam
Leicester, United Kingdom